Novartis

Amgen, Novartis and Banner Alzheimer's Institute Team on 2 Alzheimer's Prevention Trials
BioSpace
Tue, 10/16/18 - 08:32 pm
Amgen
Novartis
Alzheimer's disease
preventative medicine
7 drugmakers to watch during Q3 earnings
Biopharma Dive
Mon, 10/15/18 - 12:31 pm
earnings
Novartis
Gilead Sciences
Amgen
Pfizer
GSK
AbbVie
Regeneron
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Motley Fool
Fri, 10/12/18 - 11:40 pm
Momenta Pharmaceuticals
Teva Pharmaceuticals
Copaxone
Novartis
biosimilars
Glatopa
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Pharmaforum
Fri, 10/12/18 - 10:24 am
Novartis
Sandoz
AbbVie
Humira
biosimilars
Europe
Gilenya beats Copaxone head-to-head at higher dose, study finds
Biopharma Dive
Thu, 10/11/18 - 11:13 pm
Novartis
Teva Pharmaceutical
MS
Copaxone
Gilenya
Roche and Novartis Strengthen Their Presence in the MS Market
BioSpace
Thu, 10/11/18 - 09:35 am
Genentech
Roche
Ocrevus
Novartis
siponimod
FDA
MS
multiple sclerosis
Novartis drug cuts serious complications in sickle cell disease
CP WIre
Wed, 10/10/18 - 10:15 am
Novartis
sickle cell disease
crizanlizumab
Novartis cozies up to Silicon Valley with new lab
Fierce Biotech
Tue, 10/9/18 - 11:32 am
Novartis
innovation
San Francisco
Silicon Valley
R&D
Novartis Biome
Novartis bets PRV on its next big multiple sclerosis drug — eyes US, EU approvals in ’19
Endpoints
Mon, 10/8/18 - 10:45 am
Novartis
siponimod
MS
multiple sclerosis
Europe
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
biosimilars
Pfizer
Biogen
Novartis
Amgen
Mylan Labs
Insight: How Novartis built a ‘money-filled moat’ to market Kymriah
Biopharma Reporter
Thu, 10/4/18 - 06:59 pm
Novartis
Kymriah
competition
drug marketing
CAR-T
Boston Pharma Doubles Pipeline with 2 Deals with Novartis and GSK
BioSpace
Wed, 10/3/18 - 11:58 am
Boston Pharmaceuticals
GSK
Novartis
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
Fierce Pharma
Wed, 10/3/18 - 11:49 am
Roche
Novartis
Xolair
Xolair pen
FDA
Vas Narasimhan, Novartis CEO, explains reasons behind 2,100 jobs cut
GoinPharma
Sun, 09/30/18 - 03:49 pm
Novartis
layoffs
Vas Narasimhan
Pharma CEOs
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
Fri, 09/28/18 - 12:32 pm
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Novartis signs manufacturing deal for Kymriah in China
BioCentury
Thu, 09/27/18 - 11:00 pm
Novartis
Kymriah
China
drug manufacturing
Mylan and Novartis to FDA: Where are the Suffixes?
RAPS.org
Wed, 09/26/18 - 07:23 pm
Mylan Labs
Novartis
drug names
biosimilars
biologics
Novartis to cut 2,200 jobs in Switzerland to boost profits
Pharmaforum
Tue, 09/25/18 - 09:41 am
Novartis
layoffs
Switzerland
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
Mon, 09/24/18 - 03:37 pm
UK
Roche
Avastin
wet age-related macular degeneration
Novartis
Bayer
Novartis plans to file for new Lucentis indication in ROP
Pharmaceutical Business Review
Mon, 09/24/18 - 09:39 am
Novartis
Lucentis
ROP
retinopathy of prematurity

Pages